Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency - Summary - MDSpire

Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency

  • By

  • Andrea Sappl

  • Annie M. Sriramachandran

  • Christian Lottspeich

  • Katharina Vill

  • Monika Morak

  • Ann-Christin Welp

  • Orsela Dervishi

  • Martin Bidlingmaier

  • Sonja Kunz

  • Nicole Reisch

  • May 15, 2026

Share

Objective:

To determine the frequency of congenital adrenal hyperplasia with tenascin-X gene deficiency (CAH-X) within the Munich cohort of CAH patients and assess its clinical implications.

Key Findings:
  • 5% of the cohort carried the CAH-X CH1 chimera.
  • Increased muscle echogenicity was observed in CAH-X patients compared to controls.
  • Cardiac abnormalities, including persistent truncus arteriosus and relaxation disorder, were identified in CAH-X patients, highlighting significant health risks.
Interpretation:

The findings highlight the critical importance of genetic and clinical screening in CAH-X syndrome to monitor potential cardiovascular and joint issues.

Limitations:
  • The study's sample size was limited to a single cohort in Munich.
  • Long-term follow-up data on clinical outcomes were not provided.
  • The lack of diversity in the cohort may limit the generalizability of the findings.
Conclusion:

Regular follow-up examinations are essential for patients with CAH-X syndrome due to the associated risks of cardiac and joint abnormalities, which could significantly impact patient health.

Original Source(s)

Related Content